markers
15,821 rows
This data as json, CSV (advanced)
Suggested facets: Regulation, Exosomal, Organism
SALID ▼ | BiomarkerName | BiomarkerType | SamplingMethod | CollectionMethod | AnalysisMethod | CollectionSite | DiseaseCategory | DiseaseName | DiseaseSubtype | FoldChange | Regulation | Exosomal | Organism | PMID | YearOfPublication | ID | Biomarker | Sequence |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SAL_10001 | C-reactive protein | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.39 | Upregulated | Homo sapiens | 29129647 | 2017 | P02741 | Protein | MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP | ||
SAL_10002 | Interleukin-1-beta | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 3.18 | Upregulated | Homo sapiens | 29129647 | 2017 | P01584 | Protein | MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS | ||
SAL_10003 | Interleukin-1-ra | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 0.53 | Downregulated | Homo sapiens | 29129647 | 2017 | P18510 | Protein | MEICRGLRSHLITLLLFLFHSETICRPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE | ||
SAL_10004 | Interleukin-6 | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.08 | Upregulated | Homo sapiens | 29129647 | 2017 | P05231 | Protein | MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM | ||
SAL_10005 | Interleukin-8 | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.08 | Upregulated | Homo sapiens | 29129647 | 2017 | P10145 | Protein | MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS | ||
SAL_10006 | Lactoferrin | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.46 | Upregulated | Homo sapiens | 29129647 | 2017 | P02788 | Protein | MKLVFLVLLFLGALGLCLAGRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQAIAENRADAVTLDGGFIYEAGLAPYKLRPVAAEVYGTERQPRTHYYAVAVVKKGGSFQLNELQGLKSCHTGLRRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARFFSASCVPGADKGQFPNLCRLCAGTGENKCAFSSQEPYFSYSGAFKCLRDGAGDVAFIRESTVFEDLSDEAERDEYELLCPDNTRKPVDKFKDCHLARVPSHAVVARSVNGKEDAIWNLLRQAQEKFGKDKSPKFQLFGSPSGQKDLLFKDSAIGFSRVPPRIDSGLYLGSGYFTAIQNLRKSEEEVAARRARVVWCAVGEQELRKCNQWSGLSEGSVTCSSASTTEDCIALVLKGEADAMSLDGGYVYTAGKCGLVPVLAENYKSQQSSDPDPNCVDRPVEGYLAVAVVRRSDTSLTWNSVKGKKSCHTAVDRTAGWNIPMGLLFNQTGSCKFDEYFSQSCAPGSDPRSNLCALCIGDEQGENKCVPNSNERYYGYTGAFRCLAENAGDVAFVKDVTVLQNTDGNNNEAWAKDLKLADFALLCLDGKRKPVTEARSCHLAMAPNHAVVSRMDKVERLKQVLLHQQAKFGRNGSDCPDKFCLFQSETKNLLFNDNTECLARLHGKTTYEKYLGPQYVAGITNLKKCSTSPLLEACEFLRK | ||
SAL_10007 | MMP-8 | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 4.725 | Upregulated | Homo sapiens | 29129647 | 2017 | P22894 | Protein | MFSLKTLPFLLLLHVQISKAFPVSSKEKNTKTVQDYLEKFYQLPSNQYQSTRKNGTNVIVEKLKEMQRFFGLNVTGKPNEETLDMMKKPRCGVPDSGGFMLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYGLSSNPIQPTGPSTPKPCDPSLTFDAITTLRGEILFFKDRYFWRRHPQLQRVEMNFISLFWPSLPTGIQAAYEDFDRDLIFLFKGNQYWALSGYDILQGYPKDISNYGFPSSVQAIDAAVFYRSKTYFFVNDQFWRYDNQRQFMEPGYPKSISGAFPGIESKVDAVFQQEHFFHVFSGPRYYAFDLIAQRVTRVARGNKWLNCRYG | ||
SAL_10008 | MMP-9 | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 4.04 | Upregulated | Homo sapiens | 29129647 | 2017 | P14780 | Protein | MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRSYSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTQDGNADGKPCQFPFIFQGQSYSACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYSTCTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYGPRPEPEPRPPTTTTPQPTAPPTVCPTGPPTVHPSERPTAGPTGPPSAGPTGPPTAGPSTATTVPLSPVDDACNVNIFDAIAEIGNQLYLFKDGKYWRFSEGRGSRPQGPFLIADKWPALPRKLDSVFEERLSKKLFFFSGRQVWVYTGASVLGPRRLDKLGLGADVAQVTGALRSGRGKMLLFSGRRLWRFDVKAQMVDPRSASEVDRMFPGVPLDTHDVFQYREKAYFCQDRFYWRVSSRSELNQVDQVGYVTYDILQCPED | ||
SAL_10009 | PDGFB | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.4 | Upregulated | Homo sapiens | 29129647 | 2017 | P01127 | Protein | MNRCWALFLSLCCYLRLVSAEGDPIPEELYEMLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGRRSLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVTRSPGGSQEQRAKTPQTRVTIRTVRVRRPPKGKHRKFKHTHDKTALKETLGA | ||
SAL_10010 | TNF-alpha | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 0.5 | Downregulated | Homo sapiens | 29129647 | 2017 | Q5STB3 | Protein | MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL | ||
SAL_10011 | Vascular endothelial growth factor | Diagnostic | Fifty-seven participants were divided into a non-periodontitis group and a periodontitis group | Saliva (25 mL) was collected in the daytime, using a sterile container, and before any intrusive periodontal treatment to avoid blood contamination. | ELISA | Whole Saliva | Dental Disorder | Periodontitis | 1.14 | Upregulated | Homo sapiens | 29129647 | 2017 | Q9UNS8 | Protein | MNFLLSWVHWSLALLLYLHHAK | ||
SAL_10012 | Eotaxin | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P51671 | Protein | MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP | ||||
SAL_10013 | Epidermal growth factor | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P01133 | Protein | MLLTLIILLPVVSKFSFVSLSAPQHWSCPEGTLAGNGNSTCVGPAPFLIFSHGNSIFRIDTEGTNYEQLVVDAGVSVIMDFHYNEKRIYWVDLERQLLQRVFLNGSRQERVCNIEKNVSGMAINWINEEVIWSNQQEGIITVTDMKGNNSHILLSALKYPANVAVDPVERFIFWSSEVAGSLYRADLDGVGVKALLETSEKITAVSLDVLDKRLFWIQYNREGSNSLICSCDYDGGSVHISKHPTQHNLFAMSLFGDRIFYSTWKMKTIWIANKHTGKDMVRINLHSSFVPLGELKVVHPLAQPKAEDDTWEPEQKLCKLRKGNCSSTVCGQDLQSHLCMCAEGYALSRDRKYCEDVNECAFWNHGCTLGCKNTPGSYYCTCPVGFVLLPDGKRCHQLVSCPRNVSECSHDCVLTSEGPLCFCPEGSVLERDGKTCSGCSSPDNGGCSQLCVPLSPVSWECDCFPGYDLQLDEKSCAASGPQPFLLFANSQDIRHMHFDGTDYGTLLSQQMGMVYALDHDPVENKIYFAHTALKWIERANMDGSQRERLIEEGVDVPEGLAVDWIGRRFYWTDRGKSLIGRSDLNGKRSKIITKENISQPRGIAVHPMAKRLFWTDTGINPRIESSSLQGLGRLVIASSDLIWPSGITIDFLTDKLYWCDAKQSVIEMANLDGSKRRRLTQNDVGHPFAVAVFEDYVWFSDWAMPSVMRVNKRTGKDRVRLQGSMLKPSSLVVVHPLAKPGADPCLYQNGGCEHICKKRLGTAWCSCREGFMKASDGKTCLALDGHQLLAGGEVDLKNQVTPLDILSKTRVSEDNITESQHMLVAEIMVSDQDDCAPVGCSMYARCISEGEDATCQCLKGFAGDGKLCSDIDECEMGVPVCPPASSKCINTEGGYVCRCSEGYQGDGIHCLDIDECQLGEHSCGENASCTNTEGGYTCMCAGRLSEPGLICPDSTPPPHLREDDHHYSVRNSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELRHAGHGQQQKVIVVAVCVVVLVMLLLLSLWGAHYYRTQKLLSKNPKNPYEESSRDVRSRRPADTEDGMSSCPQPWFVVIKEHQDLKNGGQPVAGEDGQAADGSMQPTSWRQEPQLCGMGTEQGCWIPVSSDKGSCPQVMERSFHMPSYGTQTLEGGVEKPHSLLSANPLWQQRALDPPHQMELTQ | ||||
SAL_10014 | Granulocyte colony stimulating factor | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P04141 | Protein | MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE | ||||
SAL_10015 | Growth-related oncogene | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P01106 | Protein | MPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA | ||||
SAL_10016 | Interferon gamma | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | Q14624 | Protein | MKPPRPVRTCSKVLVLLSLLAIHQTTTAEKNGIDIYSLTVDSRVSSRFAHTVVTSRVVNRANTVQEATFQMELPKKAFITNFSMIIDGMTYPGIIKEKAEAQAQYSAAVAKGKSAGLVKATGRNMEQFQVSVSVAPNAKITFELVYEELLKRRLGVYELLLKVRPQQLVKHLQMDIHIFEPQGISFLETESTFMTNQLVDALTTWQNKTKAHIRFKPTLSQQQKSPEQQETVLDGNLIIRYDVDRAISGGSIQIENGYFVHYFAPEGLTTMPKNVVFVIDKSGSMSGRKIQQTREALIKILDDLSPRDQFNLIVFSTEATQWRPSLVPASAENVNKARSFAAGIQALGGTNINDAMLMAVQLLDSSNQEERLPEGSVSLIILLTDGDPTVGETNPRSIQNNVREAVSGRYSLFCLGFGFDVSYAFLEKLALDNGGLARRIHEDSDSALQLQDFYQEVANPLLTAVTFEYPSNAVEEVTQNNFRLLFKGSEMVVAGKLQDRGPDVLTATVSGKLPTQNITFQTESSVAEQEAEFQSPKYIFHNFMERLWAYLTIQQLLEQTVSASDADQQALRNQALNLSLAYSFVTPLTSMVVTKPDDQEQSQVAEKPMEGESRNRNVHSGSTFFKYYLQGAKIPKPEASFSPRRGWNRQAGAAGSRMNFRPGVLSSRQLGLPGPPDVPDHAAYHPFRRLAILPASAPPATSNPDPAVSRVMNMKIEETTMTTQTPAPIQAPSAILPLPGQSVERLCVDPRHRQGPVNLLSDPEQGVEVTGQYEREKAGFSWIEVTFKNPLVWVHASPEHVVVTRNRRSSAYKWKETLFSVMPGLKMTMDKTGLLLLSDPDKVTIGLLFWDGRGEGLRLLLRDTDRFSSHVGGTLGQFYQEVLWGSPAASDDGRRTLRVQGNDHSATRERRLDYQEGPPGVEISCWSVEL | ||||
SAL_10017 | Interferon gamma-induced protein-10 | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P02778 | Protein | MNQTAILICCLIFLTLSGIQGVPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP | ||||
SAL_10018 | Interleukin-10 | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P22301 | Protein | MHSSALLCCLVLLTGVRASPGQGTQSENSCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPDIKAHVNSLGENLKTLRLRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGIYKAMSEFDIFINYIEAYMTMKIRN | ||||
SAL_10019 | Interleukin-1-alpha | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P01583 | Protein | MAKVPDMFEDLKNCYSENEEDSSSIDHLSLNQKSFYHVSYGPLHEGCMDQSVSLSISETSKTSKLTFKESMVVVATNGKVLKKRRLSLSQSITDDDLEAIANDSEEEIIKPRSAPFSFLSNVKYNFMRIIKYEFILNDALNQSIIRANDQYLTAAALHNLDEAVKFDMGAYKSSKDDAKITVILRISKTQLYVTAQDEDQPVLLKEMPEIPKTITGSETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWVCLAGGPPSITDFQILENQA | ||||
SAL_10020 | Interleukin-1-beta | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P01584 | Protein | MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS | ||||
SAL_10021 | Interleukin-6 | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P05231 | Protein | MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM | ||||
SAL_10022 | Interleukin-8 | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P10145 | Protein | MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS | ||||
SAL_10023 | Macrophage inflammatory protein-1-beta | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P13236 | Protein | MKLCVTVLSLLMLVAAFCSPALSAPMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN | ||||
SAL_10024 | Tumour necrosis factor alpha | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | P01375 | Protein | MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL | ||||
SAL_10025 | Vascular endothelial growth factor | Saliva and plasma samples were obtained from forty one OSCC patients and twenty four non-oral cancer patients | Blood (3 mL) and saliva samples were collected from each subject before any surgery. | The Human Cytokine/Chemokine Magnetic Bead Pane | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | Homo sapiens | 29174861 | 2018 | Q9UNS8 | Protein | MNFLLSWVHWSLALLLYLHHAK | ||||
SAL_10026 | Haptoglobin | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | Homo sapiens | 29199150 | 2018 | H0Y300 | Protein | MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTEGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTEGDGEAMPCSLPHVNLRVTFTSPADVGKEGMLMMMSPSPRVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMVSHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHPNYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVMLPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN | |||
SAL_10027 | Haptoglobin-related protein | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | Homo sapiens | 29199150 | 2018 | P00739 | Protein | MSDLGAVISLLLWGRQLFALYSGNDVTDISDDRFPKPPEIANGYVEHLFRYQCKNYYRLRTEGDGVYTLNDKKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMVSHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHPNYHQVDIGLIKLKQKVLVNERVMPICLPSKNYAEVGRVGYVSGWGQSDNFKLTDHLKYVMLPVADQYDCITHYEGSTCPKWKAPKSPVGVQPILNEHTFCVGMSKYQEDTCYGDAGSAFAVHDLEEDTWYAAGILSFDKSCAVAEYGVYVKVTSIQHWVQKTIAEN | |||
SAL_10028 | Ig alpha-2 chain C region | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | Homo sapiens | 29199150 | 2018 | P01877 | Protein | ASPTSPKVFPLSLDSTPQDGNVVVACLVQGFFPQEPLSVTWSESGQNVTARNFPPSQDASGDLYTTSSQLTLPATQCPDGKSVTCHVKHYTNSSQDVTVPCRVPPPPPCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGATFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAQPWNHGETFTCTAAHPELKTPLTANITKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTYAVTSILRVAAEDWKKGETFSCMVGHEALPLAFTQKTIDRMAGKPTHINVSVVMAEADGTCY | |||
SAL_10029 | Immunoglobulin J chain | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | Homo sapiens | 29199150 | 2018 | P01591 | Protein | MKNHLLFWGVLAVFIKAVHVKAQEDERIVLVDNKCKCARITSRIIRSSEDPNEDIVERNIRIIVPLNNRENISDPTSPLRTRFVYHLSDLCKKCDPTEVELDNQIVTATQSNICDEDSATETCYTYDRNKCYTAVVPLVYGGETKMVETALTPDACYPD | |||
SAL_10030 | Mutant beta-actin (beta actin) | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | Homo sapiens | 29199150 | 2018 | G8FSY7 | Protein | ANREKMTQIMFETFNTPAMYVAIQAVLSPYTSGRTTGIVMDSGDGVTHTVPIYEGNALPHATLRLDLAGRELPDYLMKILTEHGYRFTTMAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPCFLGMESCGIHETTFNSIMKSDVDIRKDLYTNTVLSGGTTMYPGMAHRMQKEIAALAPSMMKIRIIAPPKRKYSVWIGG | |||
SAL_10031 | Peroxiredoxin-2 | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | upregulated | Homo sapiens | 29199150 | 2018 | P32119 | Protein | MASGNARIGKPAPDFKATAVVDGAFKEVKLSDYKGKYVVLFFYPLDFTFVCPTEIIAFSNRAEDFRKLGCEVLGVSVDSQFTHLAWINTPRKEGGLGPLNIPLLADVTRRLSEDYGVLKTDEGIAYRGLFIIDGKGVLRQITVNDLPVGRSVDEALRLVQAFQYTDEHGEVCPAGWKPGSDTIKPNVDDSKEYFSKHN | ||
SAL_10032 | Zinc-alpha-2-glycoprotein | Saliva samples were collected from ninety-two OSCC patients and eighty-three CFCs. | Following collection, saliva samples (1 ml) were centrifuged at 12,000 rpm for 15 min at 4 degreeC. The supernatant was collected. | 2-DE + LC-MS/ MS + western blot | Saliva | Cancer | Oral Cancer | Oral squamous cell carcinoma | >2 | upregulated | Homo sapiens | 29199150 | 2018 | P25311 | Protein | MVRMVPVLLSLLLLLGPAVPQENQDGRYSLTYIYTGLSKHVEDVPAFQALGSLNDLQFFRYNSKDRKSQPMGLWRQVEGMEDWKQDSQLQKAREDIFMETLKDIVEYYNDSNGSHVLQGRFGCEIENNRSSGAFWKYYYDGKDYIEFNKEIPAWVPFDPAAQITKQKWEAEPVYVQRAKAYLEEECPATLRKYLKYSKNILDRQDPPSVVVTSHQAPGEKKKLKCLAYDFYPGKIDVHWTRAGEVQEPELRGDVLHNGNGTYQSWVVVAVPPQDTAPYSCHVQHSSLAQPLVVPWEAS | ||
SAL_10033 | Actin-related protein 2/3 complex subunit | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3.9 | Upregulated | Homo sapiens | 29222021 | 2017 | O15511 | Protein | MSKNTVSSARFRKVDVDEYDENKFVDEEDGGDGQAGPDEGEVDSCLRQGNMTAALQAALKNPPINTKSQAVKDRAGSIVLKVLISFKANDIEKAVQSLDKNGVDLLMKYIYKGFESPSDNSSAMLLQWHEKALAAGGVGSIVRVLTARKTV | |||
SAL_10034 | Alpha amylase 1A | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.7 | Upregulated | Homo sapiens | 29222021 | 2017 | P0DUB6 | Protein | MKLFWLLFTIGFCWAQYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLSGLLDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMWPGDIKAILDKLHNLNSNWFPEGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFMPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRWRQIRNMVNFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL | |||
SAL_10035 | Arginine/serine-rich coiled-coil protein 2 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.2 | Downregulated | Homo sapiens | 29222021 | 2017 | Q7L4I2 | Protein | MAASDTERDGLAPEKTSPDRDKKKEQSEVSVSPRASKHHYSRSRSRSRERKRKSDNEGRKHRSRSRSKEGRRHESKDKSSKKHKSEEHNDKEHSSDKGRERLNSSENGEDRHKRKERKSSRGRSHSRSRSRERRHRSRSRERKKSRSRSRERKKSRSRSRERKKSRSRSRERKRRIRSRSRSRSRHRHRTRSRSRTRSRSRDRKKRIEKPRRFSRSLSRTPSPPPFRGRNTAMDAQEALARRLERAKKLQEQREKEMVEKQKQQEIAAAAATGGSVLNVAALLASGTQVTPQIAMAAQMAALQAKALAETGIAVPSYYNPAAVNPMKFAEQEKKRKMLWQGKKEGDKSQSAEIWEKLNFGNKDQNVKFRKLMGIKSEDEAGCSSVDEESYKTLKQQEEVFRNLDAQYEMARSQTHTQRGMGLGFTSSMRGMDAV | |||
SAL_10036 | Beta-globin | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2 | Downregulated | Homo sapiens | 29222021 | 2017 | P68871 | Protein | MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH | |||
SAL_10037 | Calcium-binding protein 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -1.9 | Downregulated | Homo sapiens | 29222021 | 2017 | C9J8G2 | Protein | MCQCVRACVCVCVCACATQRASHSALPGTTISVKDWRLCLLDQFDACARSGLSEPRSLTLRVPSCGKPLPGPGARLGREVTPCLSFAFAWCWLKMCQEEQTSYMVVQTSEEGLAADAELPGPLLMLAQNCAVMHNLLGPACIFLRKGFAENRQPDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDAFREFDTNGDGEISTSELREAMRKLLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRMMSR | |||
SAL_10038 | Carbonate dehydratase | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.9 | Upregulated | Homo sapiens | 29222021 | 2017 | P22748 | Protein | MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDRQSPINIVTTKAKVDKKLGRFFFSGYDKKQTWTVQNNGHSVMMLLENKASISGGGLPAPYQAKQLHLHWSDLPYKGSEHSLDGEHFAMEMHIVHEKEKGTSRNVKEAQDPEDEIAVLAFLVEAGTQVNEGFQPLVEALSNIPKPEMSTTMAESSLLDLLPKEEKLRHYFRYLGSLTTPTCDEKVVWTVFREPIQLHREQILAFSQKLYYDKEQTVSMKDNVRPLQQLGQRTVIKSGAPGRPLPWALPALLGPMLACLLAGFLR | |||
SAL_10039 | Chain B, Cyanomet Rhb1.1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.8 | Downregulated | Homo sapiens | 29222021 | 2017 | Protein | |||||
SAL_10040 | Collagen alpha-1(XXV) chain | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.6 | Upregulated | Homo sapiens | 29222021 | 2017 | Q9BXS0 | Protein | MLLKKHAGKGGGREPRSEDPTPAEQHCARTMPPCAVLAALLSVVAVVSCLYLGVKTNDLQARIAALESAKGAPSIHLLPDTLDHLKTMVQEKVERLLAQKSYEHMAKIRIAREAPSECNCPAGPPGKRGKRGRRGESGPPGQPGPQGPPGPKGDKGEQGDQGPRMVFPKINHGFLSADQQLIKRRLIKGDQGQAGPPGPPGPPGPRGPPGDTGKDGPRGMPGVPGEPGKPGEQGLMGPLGPPGQKGSIGAPGIPGMNGQKGEPGLPGAVGQNGIPGPKGEPGEQGEKGDAGENGPKGDTGEKGDPGSSAAGIKGEPGESGRPGQKGEPGLPGLPGLPGIKGEPGFIGPQGEPGLPGLPGTKGERGEAGPPGRGERGEPGAPGPKGKQGESGTRGPKGSKGDRGEKGDSGAQGPRGPPGQKGDQGATEIIDYNGNLHEALQRITTLTVTGPPGPPGPQGLQGPKGEQGSPGIPGMDGEQGLKGSKGDMGDPGMTGEKGGIGLPGLPGANGMKGEKGDSGMPGPQGPSIIGPPGPPGPHGPPGPMGPHGLPGPKGTDGPMGPHGPAGPKGERGEKGAMGEPGPRGPYGLPGKDGEPGLDGFPGPRGEKGDLGEKGEKGFRGVKGEKGEPGQPGLDGLDAPCQLGPDGLPMPGCWQK | |||
SAL_10041 | Cystatin SA | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.6 | Upregulated | Homo sapiens | 29222021 | 2017 | P09228 | Protein | MAWPLCTLLLLLATQAVALAWSPQEEDRIIEGGIYDADLNDERVQRALHFVISEYNKATEDEYYRRLLRVLRAREQIVGGVNYFFDIEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSFQIYEVPWEDRMSLVNSRCQEA | |||
SAL_10042 | Cystatin-S | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -1.7 | Downregulated | Homo sapiens | 29222021 | 2017 | P01036 | Protein | MARPLCTLLLLMATLAGALASSSKEENRIIPGGIYDADLNDEWVQRALHFAISEYNKATEDEYYRRPLQVLRAREQTFGGVNYFFDVEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSFEIYEVPWEDRMSLVNSRCQEA | |||
SAL_10043 | Fibroblast growth factor 8 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -4.2 | Downregulated | Homo sapiens | 29222021 | 2017 | P55075 | Protein | MGSPRSALSCLLLHLLVLCLQAQEGPGRGPALGRELASLFRAGREPQGVSQQHVREQSLVTDQLSRRLIRTYQLYSRTSGKHVQVLANKRINAMAEDGDPFAKLIVETDTFGSRVRVRGAETGLYICMNKKGKLIAKSNGKGKDCVFTEIVLENNYTALQNAKYEGWYMAFTRKGRPRKGSKTRQHQREVHFMKRLPRGHHTTEQSLRFEFLNYPPFTRSLRGSQRTWAPEPR | |||
SAL_10044 | Hemoglobin subunit alpha | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.1 | Downregulated | Homo sapiens | 29222021 | 2017 | P69905 | Protein | MVLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR | |||
SAL_10045 | Immunoglobulin A heavy chain variable region | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3.5 | Upregulated | Homo sapiens | 29222021 | 2017 | P01876 | Protein | ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPSCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY | |||
SAL_10046 | Immunoglobulin heavy chain variable region | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.9 | Downregulated | Homo sapiens | 29222021 | 2017 | A0A0J9YXZ5 | Protein | MSAADEVDGLGVARPHYGSVLDNERLTAEEMDERRRQNVAYEYLCHLEEAKRWMEACLGEDLPPTTELEEGLRNGVYLAKLGNFFSPKVVSLKKIYDREQTRYKATGLHFRHTDNVIQWLNAMDEIGLPKIFYPETTDIYDRKNMPRCIYCIHALSLYLFKLGLAPQIQDLYGKVDFTEEEINNMKTELEKYGIQMPAFSKIGGILANELSVDEAALHAAVIAINEAIDRRIPADTFAALKNPNAMLVNLEEPLASTYQDILYQAKQDKMTNAKNRTENSERERDVYEELLTQAEIQGNINKVNTFSALANIDLALEQGDALALFRALQSPALGLRGLQQQNSDWYLKQLLSDKQQKRQSGQTDPLQKEELQSGVDAANSAAQQYQRRLAAVALINAAIQKGVAEKTVLELMNPEAQLPQVYPFAADLYQKELATLQRQSPEHNLTHPELSVAVEMLSSVALINRALESGDVNTVWKQLSSSVTGLTNIEEENCQRYLDELMKLKAQAHAENNEFITWNDIQACVDHVNLVVQEEHERILAIGLINEALDEGDAQKTLQALQIPAAKLEGVLAEVAQHYQDTLIRAKREKAQEIQDESAVLWLDEIQGGIWQSNKDTQEAQKFALGIFAINEAVESGDVGKTLSALRSPDVGLYGVIPECGETYHSDLAEAKKKKLAVGDNNSKWVKHWVKGGYYYYHNLETQEGGWDEPPNFVQNSMQLSREEIQSSISGVTAAYNREQLWLANEGLITRLQARCRGYLVRQEFRSRMNFLKKQIPAITCIQSQWRGYKQKKAYQDRLAYLRSHKDEVVKIQSLARMHQARKRYRDRLQYFRDHINDIIKIQAFIRANKARDDYKTLINAEDPPMVVVRKFVHLLDQSDQDFQEELDLMKMREEVITLIRSNQQLENDLNLMDIKIGLLVKNKITLQDVVSHSKKLTKKNKEQLSDMMMINKQKGGLKALSKEKREKLEAYQHLFYLLQTNPTYLAKLIFQMPQNKSTKFMDSVIFTLYNYASNQREEYLLLRLFKTALQEEIKSKVDQIQEIVTGNPTVIKMVVSFNRGARGQNALRQILAPVVKEIMDDKSLNIKTDPVDIYKSWVNQMESQTGEASKLPYDVTPEQALAHEEVKTRLDSSIRNMRAVTDKFLSAIVSSVDKIPYGMRFIAKVLKDSLHEKFPDAGEDELLKFCAFLQ | |||
SAL_10047 | Indoleamine 2,3-dioxygenase 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.9 | Upregulated | Homo sapiens | 29222021 | 2017 | P14902 | Protein | MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG | |||
SAL_10048 | Interferon, gamma-inducible protein 16 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.1 | Upregulated | Homo sapiens | 29222021 | 2017 | Q96PP8 | Protein | MALEIHMSDPMCLIENFNEQLKVNQEALEILSAITQPVVVVAIVGLYRTGKSYLMNKLAGKNKGFSVASTVQSHTKGIWIWCVPHPNWPNHTLVLLDTEGLGDVEKADNKNDIQIFALALLLSSTFVYNTVNKIDQGAIDLLHNVTELTDLLKARNSPDLDRVEDPADSASFFPDLVWTLRDFCLGLEIDGQLVTPDEYLENSLRPKQGSDQRVQNFNLPRLCIQKFFPKKKCFIFDLPAHQKKLAQLETLPDDELEPEFVQQVTEFCSYIFSHSMTKTLPGGIMVNGSRLKNLVLTYVNAISSGDLPCIENAVLALAQRENSAAVQKAIAHYDQQMGQKVQLPMETLQELLDLHRTSEREAIEVFMKNSFKDVDQSFQKELETLLDAKQNDICKRNLEASSDYCSALLKDIFGPLEEAVKQGIYSKPGGHNLFIQKTEELKAKYYREPRKGIQAEEVLQKYLKSKESVSHAILQTDQALTETEKKKKEAQVKAEAEKAEAQRLAAIQRQNEQMMQERERLHQEQVRQMEIAKQNWLAEQQKMQEQQMQEQAAQLSTTFQAQNRSLLSELQHAQRTVNNDDPCVLL | |||
SAL_10049 | Keratin 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.3 | Upregulated | Homo sapiens | 29222021 | 2017 | Q7Z3Z0 | Protein | MSLRLSSASRRSCPRPTTGSLRLYGGGTSFGTGNSCGISGIGSGFSSAFGGSSSGGNTGGGNPCAGFTVNERGLLSGNEKVTMQNLNDRLASYLDSVHALEEANADLEQKIKGWYEKFGPGSCRGLDHDYSRYFPIIDDLKNQIIASTTSNANAVLQIDNARLTADDFRLKYENELALHQSVEADVNGLRRVLDEITLCRTDLEIQYETLSEEMTYLKKNHKEEMQVLQCAAGGNVNVEMNAAPGVDLTVLLNNMRAEYEALAEQNRRDAEAWFNEKSASLQQQISEDVGATTSARNELTEMKRTLQTLEIELQSLLATKHSLECSLTETESNYCAQLAQIQAQIGALEEQLHQVRTETEGQKLEYEQLLDIKLHLEKEIETYCLLIGGDDGACKSGGYKSKDYGSGNVGSQVKDPAKAIVVKKVLEEVDQRSKILTTRLHSLEEKSQSN | |||
SAL_10050 | Keratin, type I cytoskeletal 9 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.4 | Downregulated | Homo sapiens | 29222021 | 2017 | P35527 | Protein | MSCRQFSSSYLSRSGGGGGGGLGSGGSIRSSYSRFSSSGGGGGGGRFSSSSGYGGGSSRVCGRGGGGSFGYSYGGGSGGGFSASSLGGGFGGGSRGFGGASGGGYSSSGGFGGGFGGGSGGGFGGGYGSGFGGFGGFGGGAGGGDGGILTANEKSTMQELNSRLASYLDKVQALEEANNDLENKIQDWYDKKGPAAIQKNYSPYYNTIDDLKDQIVDLTVGNNKTLLDIDNTRMTLDDFRIKFEMEQNLRQGVDADINGLRQVLDNLTMEKSDLEMQYETLQEELMALKKNHKEEMSQLTGQNSGDVNVEINVAPGKDLTKTLNDMRQEYEQLIAKNRKDIENQYETQITQIEHEVSSSGQEVQSSAKEVTQLRHGVQELEIELQSQLSKKAALEKSLEDTKNRYCGQLQMIQEQISNLEAQITDVRQEIECQNQEYSLLLSIKMRLEKEIETYHNLLEGGQEDFESSGAGKIGLGGRGGSGGSYGRGSRGGSGGSYGGGGSGGGYGGGSGSRGGSGGSYGGGSGSGGGSGGGYGGGSGGGHSGGSGGGHSGGSGGNYGGGSGSGGGSGGGYGGGSGSRGGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGKSSHS | |||
SAL_10051 | Keratin, type II cytoskeletal 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -1.8 | Downregulated | Homo sapiens | 29222021 | 2017 | P04264 | Protein | MSRQFSSRSGYRSGGGFSSGSAGIINYQRRTTSSSTRRSGGGGGRFSSCGGGGGSFGAGGGFGSRSLVNLGGSKSISISVARGGGRGSGFGGGYGGGGFGGGGFGGGGFGGGGIGGGGFGGFGSGGGGFGGGGFGGGGYGGGYGPVCPPGGIQEVTINQSLLQPLNVEIDPEIQKVKSREREQIKSLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTRTHNLEPYFESFINNLRRRVDQLKSDQSRLDSELKNMQDMVEDYRNKYEDEINKRTNAENEFVTIKKDVDGAYMTKVDLQAKLDNLQQEIDFLTALYQAELSQMQTQISETNVILSMDNNRSLDLDSIIAEVKAQYEDIAQKSKAEAESLYQSKYEELQITAGRHGDSVRNSKIEISELNRVIQRLRSEIDNVKKQISNLQQSISDAEQRGENALKDAKNKLNDLEDALQQAKEDLARLLRDYQELMNTKLALDLEIATYRTLLEGEESRMSGECAPNVSVSVSTSHTTISGGGSRGGGGGGYGSGGSSYGSGGGSYGSGGGGGGGRGSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYRGGSGGGGGGSSGGRGSGGGSSGGSIGGRGSSSGGVKSSGGSSSVKFVSTTYSGVTR | |||
SAL_10052 | Keratin, type II cytoskeletal 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 7.1 | Upregulated | Homo sapiens | 29222021 | 2017 | P04264 | Protein | MSRQFSSRSGYRSGGGFSSGSAGIINYQRRTTSSSTRRSGGGGGRFSSCGGGGGSFGAGGGFGSRSLVNLGGSKSISISVARGGGRGSGFGGGYGGGGFGGGGFGGGGFGGGGIGGGGFGGFGSGGGGFGGGGFGGGGYGGGYGPVCPPGGIQEVTINQSLLQPLNVEIDPEIQKVKSREREQIKSLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTRTHNLEPYFESFINNLRRRVDQLKSDQSRLDSELKNMQDMVEDYRNKYEDEINKRTNAENEFVTIKKDVDGAYMTKVDLQAKLDNLQQEIDFLTALYQAELSQMQTQISETNVILSMDNNRSLDLDSIIAEVKAQYEDIAQKSKAEAESLYQSKYEELQITAGRHGDSVRNSKIEISELNRVIQRLRSEIDNVKKQISNLQQSISDAEQRGENALKDAKNKLNDLEDALQQAKEDLARLLRDYQELMNTKLALDLEIATYRTLLEGEESRMSGECAPNVSVSVSTSHTTISGGGSRGGGGGGYGSGGSSYGSGGGSYGSGGGGGGGRGSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYRGGSGGGGGGSSGGRGSGGGSSGGSIGGRGSSSGGVKSSGGSSSVKFVSTTYSGVTR | |||
SAL_10053 | Lipocalin 2 receptor | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.5 | Upregulated | Homo sapiens | 29222021 | 2017 | Q8WUG5 | Protein | MASDPIFTLAPPLHCHYGAFPPNASGWEQPPNASGVSVASAALAASAASRVATSTDPSCSGFAPPDFNHCLKDWDYNGLPVLTTNAIGQWDLVCDLGWQVILEQILFILGFASGYLFLGYPADRFGRRGIVLLTLGLVGPCGVGGAAAGSSTGVMALRFLLGFLLAGVDLGVYLMRLELCDPTQRLRVALAGELVGVGGHFLFLGLALVSKDWRFLQRMITAPCILFLFYGWPGLFLESARWLIVKRQIEEAQSVLRILAERNRPHGQMLGEEAQEALQDLENTCPLPATSSFSFASLLNYRNIWKNLLILGFTNFIAHAIRHCYQPVGGGGSPSDFYLCSLLASGTAALACVFLGVTVDRFGRRGILLLSMTLTGIASLVLLGLWDCEHPIFPTVWAQQGNPNRDLNEAAITTFSVLGLFSSQAAAILSTLLAAEVIPTTVRGRGLGLIMALGALGGLSGPAQRLHMGHGAFLQHVVLAACALLCILSIMLLPETKRKLLPEVLRDGELCRRPSLLRQPPPTRCDHVPLLATPNPAL | |||
SAL_10054 | Mitochondrial ribosomal protein L46, isoform CRA_d | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.1 | Upregulated | Homo sapiens | 29222021 | 2017 | Q3SZ22 | Protein | MAAPTRRTVLGLARCWRRFESPWSLGSRSLTLAAAPSNSASPWRLLGALCLQRPPLVSKQLTPMQEEMAALLQQMEIERSLYSDHELRALDEAEQLEKKKSDLYEEKDEKNILLVQDLEDMWEQKFLQFKPGARITDADVKNDRSSLHRKLDRNLILLVKDKLGDQDVWMLPQAEWQPGETLRQTAERTLATLSENNLEAKFLGNAPCGHYKFKFPQAVRAEGSLGAKIFFFKALLLTGDFSPAVEKGRHVWASKEELGDYLKPKYLAQVRRFLLDL | |||
SAL_10055 | Mitochondrial tRNA-specific 2- thiouridylase 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.6 | Upregulated | Homo sapiens | 29222021 | 2017 | O75648 | Protein | MQALRHVVCALSGGVDSAVAALLLRRRGYQVTGVFMKNWDSLDEHGVCTADKDCEDAYRVCQILDIPFHQVSYVKEYWNDVFSDFLNEYEKGRTPNPDIVCNKHIKFSCFFHYAVDNLGADAIATGHYARTSLEDEEVFEQKHVKKPEGLFRNRFEVRNAVKLLQAADSFKDQTFFLSQVSQDALRRTIFPLGGLTKEFVKKIAAENRLHHVLQKKESMGMCFIGKRNFEHFLLQYLQPRPGHFISIEDNKVLGTHKGWFLYTLGQRANIGGLREPWYVVEKDSVKGDVFVAPRTDHPALYRDLLRTSRVHWIAEEPPAALVRDKMMECHFRFRHQMALVPCVLTLNQDGTVWVTAVQAVRALATGQFAVFYKGDECLGSGKILRLGPSAYTLQKGQRRAGMATESPSDSPEDGPGLSPLL | |||
SAL_10056 | Multimerin-1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.5 | Downregulated | Homo sapiens | 29222021 | 2017 | Q13201 | Protein | MKGARLFVLLSSLWSGGIGLNNSKHSWTIPEDGNSQKTMPSASVPPNKIQSLQILPTTRVMSAEIATTPEARTSEDSLLKSTLPPSETSAPAEGVRNQTLTSTEKAEGVVKLQNLTLPTNASIKFNPGAESVVLSNSTLKFLQSFARKSNEQATSLNTVGGTGGIGGVGGTGGVGNRAPRETYLSRGDSSSSQRTDYQKSNFETTRGKNWCAYVHTRLSPTVILDNQVTYVPGGKGPCGWTGGSCPQRSQKISNPVYRMQHKIVTSLDWRCCPGYSGPKCQLRAQEQQSLIHTNQAESHTAVGRGVAEQQQQQGCGDPEVMQKMTDQVNYQAMKLTLLQKKIDNISLTVNDVRNTYSSLEGKVSEDKSREFQSLLKGLKSKSINVLIRDIVREQFKIFQNDMQETVAQLFKTVSSLSEDLESTRQIIQKVNESVVSIAAQQKFVLVQENRPTLTDIVELRNHIVNVRQEMTLTCEKPIKELEVKQTHLEGALEQEHSRSILYYESLNKTLSKLKEVHEQLLSTEQVSDQKNAPAAESVSNNVTEYMSTLHENIKKQSLMMLQMFEDLHIQESKINNLTVSLEMEKESLRGECEDMLSKCRNDFKFQLKDTEENLHVLNQTLAEVLFPMDNKMDKMSEQLNDLTYDMEILQPLLEQGASLRQTMTYEQPKEAIVIRKKIENLTSAVNSLNFIIKELTKRHNLLRNEVQGRDDALERRINEYALEMEDGLNKTMTIINNAIDFIQDNYALKETLSTIKDNSEIHHKCTSDMETILTFIPQFHRLNDSIQTLVNDNQRYNFVLQVAKTLAGIPRDEKLNQSNFQKMYQMFNETTSQVRKYQQNMSHLEEKLLLTTKISKNFETRLQDIESKVTQTLIPYYISVKKGSVVTNERDQALQLQVLNSRFKALEAKSIHLSINFFSLNKTLHEVLTMCHNASTSVSELNATIPKWIKHSLPDIQLLQKGLTEFVEPIIQIKTQAALSNLTCCIDRSLPGSLANVVKSQKQVKSLPKKINALKKPTVNLTTVLIGRTQRNTDNIIYPEEYSSCSRHPCQNGGTCINGRTSFTCACRHPFTGDNCTIKLVEENALAPDFSKGSYRYAPMVAFFASHTYGMTIPGPILFNNLDVNYGASYTPRTGKFRIPYLGVYVFKYTIESFSAHISGFLVVDGIDKLAFESENINSEIHCDRVLTGDALLELNYGQEVWLRLAKGTIPAKFPPVTTFSGYLLYRT | |||
SAL_10057 | Potassium voltage-gated channel subfamily V member 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.9 | Upregulated | Homo sapiens | 29222021 | 2017 | Q6PIU1 | Protein | MPSSGRALLDSPLDSGSLTSLDSSVFCSEGEGEPLALGDCFTVNVGGSRFVLSQQALSCFPHTRLGKLAVVVASYRRPGALAAVPSPLELCDDANPVDNEYFFDRSSQAFRYVLHYYRTGRLHVMEQLCALSFLQEIQYWGIDELSIDSCCRDRYFRRKELSETLDFKKDTEDQESQHESEQDFSQGPCPTVRQKLWNILEKPGSSTAARIFGVISIIFVVVSIINMALMSAELSWLDLQLLEILEYVCISWFTGEFVLRFLCVRDRCRFLRKVPNIIDLLAILPFYITLLVESLSGSQTTQELENVGRIVQVLRLLRALRMLKLGRHSTGLRSLGMTITQCYEEVGLLLLFLSVGISIFSTVEYFAEQSIPDTTFTSVPCAWWWATTSMTTVGYGDIRPDTTTGKIVAFMCILSGILVLALPIAIINDRFSACYFTLKLKEAAVRQREALKKLTKNIATDSYISVNLRDVYARSIMEMLRLKGRERASTRSSGGDDFWF | |||
SAL_10058 | PREDICTED: chromodomain- helicase-DNA-binding protein 9 isoform X9 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -4.1 | Downregulated | Homo sapiens | 29222021 | 2017 | Q3L8U1 | Protein | MTDPMMDFFDDANLFGETLEGLSDDAFVQPGPVSLVDELNLGAEFEPLHIDSLNHVQGTPTHQKMTDFEQLNQFDSIKFHHVNQSFGSPAEHVLSPHSQFNCSPIHPQNQPNGLFPDVSDGSPMWGHQTATTISNQNGSPFHQQGHSHSMHQNKSFVAHHDFALFQANEQQTQCTSLRSQQNRNNLNPGQNSLSQSKNFMNVSGPHRVNVNHPPQMTNASNSQQSISMQQFSQTSNPSAHFHKCSSHQEGNFNGPSPNMTSCSVSNSQQFSSHYSFSSNHISPNSLLQSSAVLASNHTNQTLSDFTGSNSFSPHRGIKQESTQHILNPNTSLNSNNFQILHSSHPQGNYSNSKLSPVHMNFPDPVDSGTQMGHFNDHVETNGFSSLEENLLHQVESQTEPFTGLDPEDLLQEGLLPHFDESTFGQDNSSHILDHDLDRQFTSHLVTRPSDMAQTQLQSQARSWHSSFSNHQHLHDRNHLCLQRQPPSSKKSDGSGTYTKLQNTQVRVMSEKKQRKKVESESKQEKANRIISEAIAKAKERGERNIPRVMSPENFPTASVEGKEEKKGRRMKSKPKDKDSKKTKTCSKLKEKTKIGKLIITLGKKQKRKNESSDEISDAEQMPQHTLKDQDSQKRRSNRQIKRKKYAEDIEGKQSEEEVKGSMKIKKNSAPLPGEQPLQLFVENPSEEDAAIVDKILSSRTVKKEISPGVMIDTEEFFVKYKNYSYLHCEWATEEQLLKDKRIQQKIKRFKLRQAQRAHFFADMEEEPFNPDYVEVDRVLEVSFCEDKDTGEPVIYYLVKWCSLPYEDSTWELKEDVDLAKIEEFEQLQASRPDTRRLDRPPSNIWKKIDQSRDYKNGNQLREYQLEGLNWLLFNWYNRRNCILADEMGLGKTIQSITFLYEILLTGIRGPFLIIAPLSTIANWEREFRTWTDINVVVYHGSLISRQMIQQYEMYFRDSQGRIIRGAYRFQAIITTFEMILGGCGELNAIEWRCVIIDEAHRLKNKNCKLLEGLKLMNLEHKVLLTGTPLQNTVEELFSLLHFLEPLRFPSESTFMQEFGDLKTEEQVQKLQAILKPMMLRRLKEDVEKKLAPKEETIIEVELTNIQKKYYRAILEKNFSFLSKGAGQTNVPNLVNTMMELRKCCNHPYLIKGAEEKILGEFRDTYNPAASDFHLQAMIQSAGKLVLIDKLLPKMKAGGHKVLIFSQMVRCLDILEDYLIHKRYLYERIDGRVRGNLRQAAIDRFSKPDSDRFVFLLCTRAGGLGINLTAADTCIIFDSDWNPQNDLQAQARCHRIGQNKAVKVYRLVTRNSYEREMFDRASLKLGLDKAVLQSMSGRESNVGGIQQLSKKEIEDLLRRGAYGAIMEEEDEGSKFCEEDIDQILLRRTKTITIESEGRGSTFAKASFVASGNRTDISLDDPNFWQKWAKKAEIDIEAISGRNSLVIDTPRIRKQTRPFSATKDELAELSEAESEGDEKPKLRRPCDRSNGYGRTECFRVEKNLLVYGWGRWREILSHGRFKRQLNEHDVEIICRALLAYCLVHYRGDEKIKGFIWDLITPTEDGQTRELQNHLGLSAPVPRGRKGKKVKTQTSSFDIQKAEWLRKYNPEQLLQDEGYKKHIKHHCNKVLLRVRMLYYLKQEVIGNECQKVFDGVDASDIDVWVPEPDHSEVPAEWWDFDADKSLLIGVFKHGYEKYNTIRADPALCFLERVGKPDEKAVAAEQRANDYMDGDVEDPEYKPAPAIFKDDIEDDVSSPGDLVIADGDGQLMEGDKVYWPTQSALTTRLRRLITAYQRTNKNRQIQQIQPTFSVPTSVMQPIYEEATLNPKMAAKIERQQRWTRREEADFYRVVSTFGVVFDPDRGQFDWTKFRAMARLHKKTDDSLEKYLYAFMSMCRRVCRLPSKEELVDPNIFIQPITEERASRTLYRIELLRKVREQALRHPQLFERLKLCHPNPDLPVWWECGPHDRDLLIGAAKHGVSRTDYHILRDPELSFMAAQRNYSQSKMAHSRTSTPLLQQYQVALSASPLTSLPRLLDAKGIILEEMKVK… | |||
SAL_10059 | PREDICTED: docking protein 5 isoform 4 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.2 | Upregulated | Homo sapiens | 29222021 | 2017 | Q9P104 | Protein | MASNFNDIVKQGYVRIRSRRLGIYQRCWLVFKKASSKGPKRLEKFSDERAAYFRCYHKVTELNNVKNVARLPKSTKKHAIGIYFNDDTSKTFACESDLEADEWCKVLQMECVGTRINDISLGEPDLLATGVEREQSERFNVYLMPSPNLDVHGECALQITYEYICLWDVQNPRVKLISWPLSALRRYGRDTTWFTFEAGRMCETGEGLFIFQTRDGEAIYQKVHSAALAIAEQHERLLQSVKNSMLQMKMSERAASLSTMVPLPRSAYWQHITRQHSTGQLYRLQDVSSPLKLHRTETFPAYRSEH | |||
SAL_10060 | Protein S100-A8 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3.2 | Upregulated | Homo sapiens | 29222021 | 2017 | P05109 | Protein | MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE | |||
SAL_10061 | Protein S100-A8 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3.3 | Upregulated | Homo sapiens | 29222021 | 2017 | P05109 | Protein | MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE | |||
SAL_10062 | ETS domain-containing protein Elk-4 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3 | Upregulated | Homo sapiens | 29222021 | 2017 | P28324 | Protein | MDSAITLWQFLLQLLQKPQNKHMICWTSNDGQFKLLQAEEVARLWGIRKNKPNMNYDKLSRALRYYYVKNIIKKVNGQKFVYKFVSYPEILNMDPMTVGRIEGDCESLNFSEVSSSSKDVENGGKDKPPQPGAKTSSRNDYIHSGLYSSFTLNSLNSSNVKLFKLIKTENPAEKLAEKKSPQEPTPSVIKFVTTPSKKPPVEPVAATISIGPSISPSSEETIQALETLVSPKLPSLEAPTSASNVMTAFATTPPISSIPPLQEPPRTPSPPLSSHPDIDTDIDSVASQPMELPENLSLEPKDQDSVLLEKDKVNNSSRSKKPKGLELAPTLVITSSDPSPLGILSPSLPTASLTPAFFSQTPIILTPSPLLSSIHFWSTLSPVAPLSPARLQGANTLFQFPSVLNSHGPFTLSGLDGPSTPGPFSPDLQKT | |||
SAL_10063 | Putative 40S ribosomal protein S10- like | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -1.9 | Downregulated | Homo sapiens | 29222021 | 2017 | Q9NQ39 | Protein | MLMPKKNRIAIHELLFKEGVMVAKKDVHMPKHPELADKNVPNLHVMKAMQSLKSRGCVKEQFAWRHFYWYLTNEGSQYLRDYLHLPPEIVPATLHLPPEIVPATLHRSRPETGRPRPKGLEGKRPARLTRREADRDTYRRCSVPPGADKKAEAGAGSATEFQFRGRCGRGRGQPPQ | |||
SAL_10064 | Putative uncharacterized protein ENST00000281581 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.6 | Upregulated | Homo sapiens | 29222021 | 2017 | Protein | |||||
SAL_10065 | RNMT-activating mini protein | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2 | Downregulated | Homo sapiens | 29222021 | 2017 | Q9BTL3 | Protein | MTDTAEAVPKFEEMFASRFTENDKEYQEYLKRPPESPPIVEEWNSRAGGNQRNRGNRLQDNRQFRGRDNRWGWPSDNRSNQWHGRSWGNNYPQHRQEPYYPQQYGHYGYNQRPPYGYY | |||
SAL_10066 | Sentrin-specific protease 1 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2 | Downregulated | Homo sapiens | 29222021 | 2017 | Q9P0U3 | Protein | MDDIADRMRMDAGEVTLVNHNSVFKTHLLPQTGFPEDQLSLSDQQILSSRQGHLDRSFTCSTRSAAYNPSYYSDNPSSDSFLGSGDLRTFGQSANGQWRNSTPSSSSSLQKSRNSRSLYLETRKTSSGLSNSFAGKSNHHCHVSAYEKSFPIKPVPSPSWSGSCRRSLLSPKKTQRRHVSTAEETVQEEEREIYRQLLQMVTGKQFTIAKPTTHFPLHLSRCLSSSKNTLKDSLFKNGNSCASQIIGSDTSSSGSASILTNQEQLSHSVYSLSSYTPDVAFGSKDSGTLHHPHHHHSVPHQPDNLAASNTQSEGSDSVILLKVKDSQTPTPSSTFFQAELWIKELTSVYDSRARERLRQIEEQKALALQLQNQRLQEREHSVHDSVELHLRVPLEKEIPVTVVQETQKKGHKLTDSEDEFPEITEEMEKEIKNVFRNGNQDEVLSEAFRLTITRKDIQTLNHLNWLNDEIINFYMNMLMERSKEKGLPSVHAFNTFFFTKLKTAGYQAVKRWTKKVDVFSVDILLVPIHLGVHWCLAVVDFRKKNITYYDSMGGINNEACRILLQYLKQESIDKKRKEFDTNGWQLFSKKSQEIPQQMNGSDCGMFACKYADCITKDRPINFTQQHMPYFRKRMVWEILHRKLL | |||
SAL_10067 | Small integral membrane protein 18 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 2.4 | Upregulated | Homo sapiens | 29222021 | 2017 | P0DKX4 | Protein | MASSHWNETTTSVYQYLGFQVQKIYPFHDNWNTACFVILLLFIFTVVSLVVLAFLYEVLDCCCCVKNKTVKDLKSEPNPLRSMMDNIRKRETEVV | |||
SAL_10068 | SPS1/STE20-related protein kinase YSK4 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.5 | Upregulated | Homo sapiens | 29222021 | 2017 | L8IBZ1 | Protein | MNSMPKPERHAESLLDICHDTNSSPTDMMTVTKNQNIILQSIGSSEESDQDDDCSHSILISEEGDPSGDGQDWQPRTEGVEIIVTFPRDVIHPQETGQEELPENNQITSGHQEWTQAHSVSFPKNIEMVGFRTKMVTTEPLLAKKEERSQELFNTNLGFLLPRPHLETIISKSVARDVPHFLKGQPRKSEEFSISDMKYSSRRIEFSLPPLSSLPMRSGLLTIPLSHKDQKATERNMPRLVSFIPKFSEPISQSDEFRPSNKQKEAPIKMLADQTLRSFDGSIWSRNTCSFWKAHHHRQHLEKEASRKSSFREGCVNIEVFHFEKGQSLVSLENFKEGNFPTGREEDNDCHGNELRRAEENAPSLSSGKKGDSGARNYEQDSEVGYTKPIKFQEALPSDIGLSQDEGTKSDKADSKSASALKGEAIELDHISEDYTLRKSLSDAVTDGPIEKLSEDHSSMETSTKISVAETTKPEMNGTVPLIHITFPGDETPKEPAITKPSLQKRKGILRSNSSLNILAHQENDKHKVKTQRNKLDSKTKTSNRTPQNFMISTEVSVKPTMHKTSIKTQVFPALGLVDPRPWQPPKFQRRMPQTERKQSAYQALKPKKPSFPCLYKNPGIEKSSVPLSAQPAEPRLNYLDLKYSDMFKEINSTANGPGIYEMFGTPVYCHMREAERHENKYHREICSAPSGRCITNKCRSSHSERSSNSRNRLSQKRPHSKPPKSSLGIKQKHRSLISKEKDFQTVGSTLQDAENGDGISETGWQIKSSGNDFLSSKDEVQPMNLVQAHEQFTEQNDFFPVSDLSIVEEVSMEESADEEDISNNQILATRLRDLHQLEELRHQTPFVLSENSWAVPSEKSSNMHVLQEEQKVASPGETNANQILTNNVDFDSFSDKSKTLRNFSSQEKQESVTSQAYQHWALFLDHDSLTNESIPYQTLGKTLNEADSISQEILDSVKNEELTDELLGCLAAELLALDEKDDNSCQIMADETDPESRDFVLSKRGNTMQELGRETTNVKIQRYSNGFRRYDKEERFFNPYEKKTFSESSLKYEESILWTKGEILGKGAYGTVYCGLTSQGQLIAVKQVALDTSDKLATVKEYQKLQEEVDLLKALKHVNIVAYLGTCLEENILSIFMEFVPGGSISSIINRFGPLPEMVFCKYTEQILQGVAYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDCFSENAADFVRACLTRDQHERPSAVQLLKHSFLKRSH | |||
SAL_10069 | SREBF1 protein | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.8 | Upregulated | Homo sapiens | 29222021 | 2017 | P36956 | Protein | MDEPPFSEAALEQALGEPCDLDAALLTDIEDMLQLINNQDSDFPGLFDPPYAGSGAGGTDPASPDTSSPGSLSPPPATLSSSLEAFLSGPQAAPSPLSPPQPAPTPLKMYPSMPAFSPGPGIKEESVPLSILQTPTPQPLPGALLPQSFPAPAPPQFSSTPVLGYPSPPGGFSTGSPPGNTQQPLPGLPLASPPGVPPVSLHTQVQSVVPQQLLTVTAAPTAAPVTTTVTSQIQQVPVLLQPHFIKADSLLLTAMKTDGATVKAAGLSPLVSGTTVQTGPLPTLVSGGTILATVPLVVDAEKLPINRLAAGSKAPASAQSRGEKRTAHNAIEKRYRSSINDKIIELKDLVVGTEAKLNKSAVLRKAIDYIRFLQHSNQKLKQENLSLRTAVHKSKSLKDLVSACGSGGNTDVLMEGVKTEVEDTLTPPPSDAGSPFQSSPLSLGSRGSGSGGSGSDSEPDSPVFEDSKAKPEQRPSLHSRGMLDRSRLALCTLVFLCLSCNPLASLLGARGLPSPSDTTSVYHSPGRNVLGTESRDGPGWAQWLLPPVVWLLNGLLVLVSLVLLFVYGEPVTRPHSGPAVYFWRHRKQADLDLARGDFAQAAQQLWLALRALGRPLPTSHLDLACSLLWNLIRHLLQRLWVGRWLAGRAGGLQQDCALRVDASASARDAALVYHKLHQLHTMGKHTGGHLTATNLALSALNLAECAGDAVSVATLAEIYVAAALRVKTSLPRALHFLTRFFLSSARQACLAQSGSVPPAMQWLCHPVGHRFFVDGDWSVLSTPWESLYSLAGNPVDPLAQVTQLFREHLLERALNCVTQPNPSPGSADGDKEFSDALGYLQLLNSCSDAAGAPAYSFSISSSMATTTGVDPVAKWWASLTAVVIHWLRRDEEAAERLCPLVEHLPRVLQESERPLPRAALHSFKAARALLGCAKAESGPASLTICEKASGYLQDSLATTPASSSIDKAVQLFLCDLLLVVRTSLWRQQQPPAPAPAAQGTSSRPQASALELRGFQRDLSSLRRLAQSFRPAMRRVFLHEATARLMAGASPTRTHQLLDRSLRRRAGPGGKGGAVAELEPRPTRREHAEALLLASCYLPPGFLSAPGQRVGMLAEAARTLEKLGDRRLLHDCQQMLMRLGGGTTVTSS | |||
SAL_10070 | Suppressor of tumorigenicity 20 protein | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.8 | Upregulated | Homo sapiens | 29222021 | 2017 | Q9HBF5 | Protein | MARSRLTATSVSQVQENGFVKKLEPKSGWMTFLEVTGKICEMLFCPEAILLTRKDTPYCETGLIFLTLTKTIANTYFYF | |||
SAL_10071 | Uncharacterized protein C9orf64 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 1.9 | Upregulated | Homo sapiens | 29222021 | 2017 | Protein | |||||
SAL_10072 | Unconventional myosin-Ic | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -2.2 | Downregulated | Homo sapiens | 29222021 | 2017 | O00159 | Protein | MALQVELVPTGEIIRVVHPHRPCKLALGSDGVRVTMESALTARDRVGVQDFVLLENFTSEAAFIENLRRRFRENLIYTYIGPVLVSVNPYRDLQIYSRQHMERYRGVSFYEVPPHLFAVADTVYRALRTERRDQAVMISGESGAGKTEATKRLLQFYAETCPAPERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRFGKYMDVQFDFKGAPVGGHILSYLLEKSRVVHQNHGERNFHIFYQLLEGGEEETLRRLGLERNPQSYLYLVKGQCAKVSSINDKSDWKVVRKALTVIDFTEDEVEDLLSIVASVLHLGNIHFAANEESNAQVTTENQLKYLTRLLSVEGSTLREALTHRKIIAKGEELLSPLNLEQAAYARDALAKAVYSRTFTWLVGKINRSLASKDVESPSWRSTTVLGLLDIYGFEVFQHNSFEQFCINYCNEKLQQLFIELTLKSEQEEYEAEGIAWEPVQYFNNKIICDLVEEKFKGIISILDEECLRPGEATDLTFLEKLEDTVKHHPHFLTHKLADQRTRKSLGRGEFRLLHYAGEVTYSVTGFLDKNNDLLFRNLKETMCSSKNPIMSQCFDRSELSDKKRPETVATQFKMSLLQLVEILQSKEPAYVRCIKPNDAKQPGRFDEVLIRHQVKYLGLLENLRVRRAGFAYRRKYEAFLQRYKSLCPETWPTWAGRPQDGVAVLVRHLGYKPEEYKMGRTKIFIRFPKTLFATEDALEVRRQSLATKIQAAWRGFHWRQKFLRVKRSAICIQSWWRGTLGRRKAAKRKWAAQTIRRLIRGFVLRHAPRCPENAFFLDHVRTSFLLNLRRQLPQNVLDTSWPTPPPALREASELLRELCIKNMVWKYCRSISPEWKQQLQQKAVASEIFKGKKDNYPQSVPRLFISTRLGTDEISPRVLQALGSEPIQYAVPVVKYDRKGYKPRSRQLLLTPNAVVIVEDAKVKQRIDYANLTGISVSSLSDSLFVLHVQRADNKQKGDVVLQSDHVIETLTKTALSANRVNSININQGSITFAGGPGRDGTIDFTPGSELLITKAKNGHLAVVAPRLNSR | |||
SAL_10073 | Zinc finger protein 268 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | -3.2 | Downregulated | Homo sapiens | 29222021 | 2017 | Q14587 | Protein | MATRVRTASIWVPPLQERNSSWDRIRKLQGQESILGQGTPGLQPLPGTPRQKQKSRRIEKVLEWLFISQEQPKITKSWGPLSFMDVFVDFTWEEWQLLDPAQKCLYRSVMLENYSNLVSLGYQHTKPDIIFKLEQGEELCMVQAQVPNQTCPNTVWKIDDLMDWHQENKDKLGSTAKSFECTTFGKLCLLSTKYLSRQKPHKCGTHGKSLKYIDFTSDYARNNPNGFQVHGKSFFHSKHEQTVIGIKYCESIESGKTVNKKSQLMCQQMYMGEKPFGCSCCEKAFSSKSYLLVHQQTHAEEKPYGCNECGKDFSSKSYLIVHQRIHTGEKLHECSECRKTFSFHSQLVIHQRIHTGENPYECCECGKVFSRKDQLVSHQKTHSGQKPYVCNECGKAFGLKSQLIIHERIHTGEKPYECNECQKAFNTKSNLMVHQRTHTGEKPYVCSDCGKAFTFKSQLIVHQGIHTGVKPYGCIQCGKGFSLKSQLIVHQRSHTGMKPYVCNECGKAFRSKSYLIIHTRTHTGEKLHECNNCGKAFSFKSQLIIHQRIHTGENPYECHECGKAFSRKYQLISHQRTHAGEKPYECTDCGKAFGLKSQLIIHQRTHTGEKPFECSECQKAFNTKSNLIVHQRTHTGEKPYSCNECGKAFTFKSQLIVHKGVHTGVKPYGCSQCAKTFSLKSQLIVHQRSHTGVKPYGCSECGKAFRSKSYLIIHMRTHTGEKPHECRECGKSFSFNSQLIVHQRIHTGENPYECSECGKAFNRKDQLISHQRTHAGEKPYGCSECGKAFSSKSYLIIHMRTHSGEKPYECNECGKAFIWKSLLIVHERTHAGVNPYKCSQCEKSFSGKLRLLVHQRMHTREKPYECSECGKAFIRNSQLIVHQRTHSGEKPYGCNECGKTFSQKSILSAHQRTHTGEKPCKCTECGKAFCWKSQLIMHQRTHVDDKH | |||
SAL_10074 | Zinc finger protein 525 | Saliva samples were collected from forty OC patients and forty age matched healthy control subjects. | Saliva was collected, immediately after sample collection, protease inhibitor was added and stored at -80degreeC till further use. | Western blotting and ELISA | Saliva | Cancer | Ovarian Cancer | 3.6 | Upregulated | Homo sapiens | 29222021 | 2017 | Q8N782 | Protein | MALPQGLLTFRDVAIEFSQEEWKCLDPAQRTLYRDVMLENYRNLVSLGISSKCTMKEFSSTAQGNTEVIHTGTLQRHERHHIGDFSFQEIEKDIHNFEFQWQEDERNGHEAPMTKIKKLMGSTEQYDHRHAGNKPIKYQLGSSFHSHLSELHIFQPKGKINNQVEKSINDASSVSTAQRISCRPKTHISNNYGDNFLNYSLLTQRQEVRMREKSFQCIESGKAFNYSSLLRKHQIIHLGEKQYKCDVCDKVFIRKRYLARHRRCHTGEKPYKCNECGKSFSQMSSLTYHHRLHTGEKPYKCEECDKAFRHNSALQRHRRIHTGEKPHKCNECGKTFSQKSYLACHRSIHTGKKPYECEECDKAFSFKSNLESHRITHTGEKPYKCNDCGKTFSHMSTLTCHRRLHTGEKPYKCEECDEAFRFKSSLERHRRIHNGEKLYKCNECGKTFSQELSLTCHCRLHSGEKPCKCGECDKAYSFK | |||
SAL_10075 | Immunoglobulin A | Diagnostic | The study involved males: 13 healthy social-drinking (C), 10 alcohol-dependent after chronic alcohol-intoxication (A), and 8 binge-drinkers after a single binge-drinking session (B). | All samples (3 mL) of the residual/resting whole saliva were collected with plastic tubes placed on ice by the spitting method. | analytical method | Saliva | Other | Alcoholism | Upregulated | Homo sapiens | 29222991 | 2018 | P01876 | Protein | ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPSCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTFTWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEELALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAAEDWKKGDTFSCMVGHEALPLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY | |||
SAL_10076 | Lactoferrin | Diagnostic | The study involved males: 13 healthy social-drinking (C), 10 alcohol-dependent after chronic alcohol-intoxication (A), and 8 binge-drinkers after a single binge-drinking session (B). | All samples (3 mL) of the residual/resting whole saliva were collected with plastic tubes placed on ice by the spitting method. | analytical method | Saliva | Other | Alcoholism | Homo sapiens | 29222991 | 2018 | P02788 | Protein | MKLVFLVLLFLGALGLCLAGRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQAIAENRADAVTLDGGFIYEAGLAPYKLRPVAAEVYGTERQPRTHYYAVAVVKKGGSFQLNELQGLKSCHTGLRRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARFFSASCVPGADKGQFPNLCRLCAGTGENKCAFSSQEPYFSYSGAFKCLRDGAGDVAFIRESTVFEDLSDEAERDEYELLCPDNTRKPVDKFKDCHLARVPSHAVVARSVNGKEDAIWNLLRQAQEKFGKDKSPKFQLFGSPSGQKDLLFKDSAIGFSRVPPRIDSGLYLGSGYFTAIQNLRKSEEEVAARRARVVWCAVGEQELRKCNQWSGLSEGSVTCSSASTTEDCIALVLKGEADAMSLDGGYVYTAGKCGLVPVLAENYKSQQSSDPDPNCVDRPVEGYLAVAVVRRSDTSLTWNSVKGKKSCHTAVDRTAGWNIPMGLLFNQTGSCKFDEYFSQSCAPGSDPRSNLCALCIGDEQGENKCVPNSNERYYGYTGAFRCLAENAGDVAFVKDVTVLQNTDGNNNEAWAKDLKLADFALLCLDGKRKPVTEARSCHLAMAPNHAVVSRMDKVERLKQVLLHQQAKFGRNGSDCPDKFCLFQSETKNLLFNDNTECLARLHGKTTYEKYLGPQYVAGITNLKKCSTSPLLEACEFLRK | ||||
SAL_10077 | Lysozyme | Diagnostic | The study involved males: 13 healthy social-drinking (C), 10 alcohol-dependent after chronic alcohol-intoxication (A), and 8 binge-drinkers after a single binge-drinking session (B). | All samples (3 mL) of the residual/resting whole saliva were collected with plastic tubes placed on ice by the spitting method. | analytical method | Saliva | Other | Alcoholism | Homo sapiens | 29222991 | 2018 | P61626 | Protein | MKALIVLGLVLLSVTVQGKVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV | ||||
SAL_10078 | Oral peroxidase | Diagnostic | The study involved males: 13 healthy social-drinking (C), 10 alcohol-dependent after chronic alcohol-intoxication (A), and 8 binge-drinkers after a single binge-drinking session (B). | All samples (3 mL) of the residual/resting whole saliva were collected with plastic tubes placed on ice by the spitting method. | analytical method | Saliva | Other | Alcoholism | Homo sapiens | 29222991 | 2018 | P04040 | Protein | MADSRDPASDQMQHWKEQRAAQKADVLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDEMAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFSTVAGESGSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPDMVWDFWSLRPESLHQVSFLFSDRGIPDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQGIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFNPFDLTKVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPDTHRHRLGPNYLHIPVNCPYRARVANYQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALEHSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQKKAVKNFTEVHPDYGSHIQALLDKYNAEKPKNAIHTFVQSGSHLAAREKANL | ||||
SAL_10079 | CRP | Diagnostic | Twenty seven women with singleton pregnancies were normal weight (NW; 18.5< body mass index [BMI] <25 kg/m2) and 35 obese (BMI ³30 kg/m2). Seventeen of the obese had gestational diabetes mellitus (GDM). | Salivary samples were collected adopting the passive drooling technique | Antioxidant Assay + ELISA | Saliva | Other | Maternal obesity | upregulated | Homo sapiens | 29343164 | 2018 | P02741 | Protein | MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP | |||
SAL_10080 | s-C-reactive protein | Diagnostic | Twenty seven women with singleton pregnancies were normal weight (NW; 18.5< body mass index [BMI] <25 kg/m2) and 35 obese (BMI ³30 kg/m2). Seventeen of the obese had gestational diabetes mellitus (GDM). | Salivary samples were collected adopting the passive drooling technique | Antioxidant Assay + ELISA | Saliva | Other | Maternal obesity | upregulated | Homo sapiens | 29343164 | 2018 | P02741 | Protein | MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP | |||
SAL_10081 | TAC | Diagnostic | Twenty seven women with singleton pregnancies were normal weight (NW; 18.5< body mass index [BMI] <25 kg/m2) and 35 obese (BMI ³30 kg/m2). Seventeen of the obese had gestational diabetes mellitus (GDM). | Salivary samples were collected adopting the passive drooling technique | Antioxidant Assay + ELISA | Saliva | Other | Maternal obesity | upregulated | Homo sapiens | 29343164 | 2018 | P20366 | Protein | MKILVALAVFFLVSTQLFAEEIGANDDLNYWSDWYDSDQIKEELPEPFEHLLQRIARRPKPQQFFGLMGKRDADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLMGKRALNSVAYERSAMQNYERRR | |||
SAL_10082 | Salivary alpha amylase | Diagnostic | This study measured dispositional positive affect in children with cancer (N = 73) and randomly assigned participants to one of three emotion regulation strategy conditions (distraction, reappraisal, or reassurance). | Whole Saliva samples were collected by passive drool 15 minutes before (Pre-task), immediately after (Post-task1), and then 15 minutes after the CPT (Post-task2). | ELISA | Whole Saliva | Other | Physiological Stress Response | Homo sapiens | 29350481 | 2019 | P04746 | Protein | MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL | ||||
SAL_10083 | Biotin--[biotin carboxyl-carrier protein] ligase | 337 patients with breast benign cyst or tumor (BB) or breast cancer (I/II stage) and 110 healthy humans were probed. | Whole saliva (about 1 mL) was collected and placed on ice. | Lectin blotting | Whole Saliva | Cancer | Breast Cancer | Homo sapiens | 29402727 | 2018 | G0AE97 | Protein | MPYGLAMSLFFIVFTWVKPCVASCIFLAFSPLFPVTPATMRGMTAQFIAPISPASQLSAARIAAFAGHHAEQCLIEVVAETGSTNADLLARVSGNGRDSGKDALRAPTLLVALTQTAGRGRAGRAWLTAPAAALTFSLAWPFASPLQALVGLPLAVGVTIAETLADFGVEVQLKWPNDVLQGGRKLAGILIETATAPDQQLWAVIGIGINLSIPEKLQEQIGRRTANLPAAAAQDRDLLLGSLLSGLAQNMWQFESEGLSAFVERWNRLHAFAGQQVAILDQGKTLHEGKALGIDQIGRLLLQTDGGSNPIAIMAGDISLRPKEG | |||||
SAL_10084 | Myelin and lymphocyte protein | 337 patients with breast benign cyst or tumor (BB) or breast cancer (I/II stage) and 110 healthy humans were probed. | Whole saliva (about 1 mL) was collected and placed on ice. | Lectin blotting | Whole Saliva | Cancer | Breast Cancer | Homo sapiens | 29402727 | 2018 | P21145 | Protein | MAPAAATGGSTLPSGFSVFTTLPDLLFIFEFIFGGLVWILVASSLVPWPLVQGWVMFVSVFCFVATTTLIILYIIGAHGGETSWVTLDAAYHCTAALFYLSASVLEALATITMQDGFTYRHYHENIAAVVFSYIATLLYVVHAVFSLIRWKSS | |||||
SAL_10085 | UEA-I | 337 patients with breast benign cyst or tumor (BB) or breast cancer (I/II stage) and 110 healthy humans were probed. | Whole saliva (about 1 mL) was collected and placed on ice. | Lectin blotting | Whole Saliva | Cancer | Breast Cancer | Homo sapiens | 29402727 | 2018 | P22972 | Protein | SDDLSFKFKNFSQNGKDLSFQGDASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGEVASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLRRAGGYFGLFEDTKDNDSSYQTVAVEFDTIGSPVNFDDPGFPHIGIDVNRVKSINAERWNKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDLKEILPEWVSVGFSGGTYIGRQATHEVLNWYFTSNLINTNS | |||||
SAL_10086 | C-reactive protein | Diagnostic | Sixty-one male undergraduate students participated in the study (age: 22-26 years). | Saliva samples were collected using the Salivette system (Sarstedt Co., NŸmbrecht, Germany) during RD and 30 minutes pre- and post-AE. | ELISA | Saliva | Psychological Response | Stress | Homo sapiens | 29445205 | 2018 | P02741 | Protein | MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP | ||||
SAL_10087 | Interleukin-1-beta | Diagnostic | Sixty-one male undergraduate students participated in the study (age: 22-26 years). | Saliva samples were collected using the Salivette system (Sarstedt Co., NŸmbrecht, Germany) during RD and 30 minutes pre- and post-AE. | ELISA | Saliva | Psychological Response | Stress | Homo sapiens | 29445205 | 2018 | P01584 | Protein | MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS | ||||
SAL_10088 | Interleukin-18 | Diagnostic | Sixty-one male undergraduate students participated in the study (age: 22-26 years). | Saliva samples were collected using the Salivette system (Sarstedt Co., NŸmbrecht, Germany) during RD and 30 minutes pre- and post-AE. | ELISA | Saliva | Psychological Response | Stress | Homo sapiens | 29445205 | 2018 | Q14116 | Protein | MAAEPVEDNCINFVAMKFIDNTLYFIAEDDENLESDYFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVKCEKISTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED | ||||
SAL_10089 | Interleukin-6 | Diagnostic | Sixty-one male undergraduate students participated in the study (age: 22-26 years). | Saliva samples were collected using the Salivette system (Sarstedt Co., NŸmbrecht, Germany) during RD and 30 minutes pre- and post-AE. | ELISA | Saliva | Psychological Response | Stress | Upregulated | Homo sapiens | 29445205 | 2018 | P05231 | Protein | MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM | |||
SAL_10090 | Salivary lactate dehydrogenase | Diagnostic | We recruited 644 men and 1171 women, aged 30-79 years, who participated in the Toon Health Study during 2011-15. | Collected stimulated whole saliva using a standard-sized tasteless and odorless gum base continuously chewed for 5 minutes | in vitro assay kits | Whole Saliva | Inflammatory Disorder | systemic inflammation | Upregulated | Homo sapiens | 29446092 | 2018 | F5H245 | Protein | MSTVKEQLIEKLIEDDENSQCKITIVGTGAVGMACAISILLKDLADELALVDVALDKLKGEMMDLQHGSLFFSTSKITSGKAGARQQEGETRLALVQRNVAIMKSIIPAIVHYSPDCKILVVSNPVDILTYIVWKISGLPVTRVIGSGCNLDSARFRYLIGEKLGVHPTSCHGWIIGEHGDSSVPLWSGVNVAGVALKTLDPKLGTDSDKEHWKNIHKQVIQSAYEIIKLKGYTSWAIGLSVMDLVGSILKNLRRVHPVSTMVKGLYGIKEELFLSIPCVLGRNGVSDVVKINLNSEEEALFKKSAETLWNIQKDLIF | |||
SAL_10091 | Salivary chromogranin A | Compared two assessments of the severities of AD and stress with the levels of stress proteins in the saliva of 30 patients with AD | Saliva samples were collected at the time of the consultation. | DCTM Protein Assay | Saliva | Skin Disorder | Atopic dermatitis | Homo sapiens | 29500830 | 2018 | P10645 | Protein | MRSAAVLALLLCAGQVTALPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSQECFETLRGDERILSILRHQNLLKELQDLALQGAKERAHQQKKHSGFEDELSEVLENQSSQAELKEAVEEPSSKDVMEKREDSKEAEKSGEATDGARPQALPEPMQESKAEGNNQAPGEEEEEEEEATNTHPPASLPSQKYPGPQAEGDSEGLSQGLVDREKGLSAEPGWQAKREEEEEEEEEAEAGEEAVPEEEGPTVVLNPHPSLGYKEIRKGESRSEALAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAVVPQGLFRGGKSGELEQEEERLSKEWEDSKRWSKMDQLAKELTAEKRLEGQEEEEDNRDSSMKLSFRARAYGFRGPGPQLRRGWRPSSREDSLEAGLPLQVRGYPEEKKEEEGSANRRPEDQELESLSAIEAELEKVAHQLQALRRG | |||||
SAL_10092 | 14-3-3 protein zeta/delta | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | Homo sapiens | 29534707 | 2018 | P63104 | Protein | MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN | ||||
SAL_10093 | Alpha-amylase | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | 2.1 | Upregulated | Homo sapiens | 29534707 | 2018 | B7ZMD7 | Protein | MKLFWLLFTIGFCWAQYSSNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIHNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLSGLLDLALGKDYVRSKIAEYMNHLIDIGVAGFRIDASKHMWPGDIKGILDKLHNLNSNWFPEGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFMPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRYFENGKDVNDWVGPPNDNGVTKEVTINPDTTCGNDWVCEHRWRQIRNMVNFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWTFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL | ||
SAL_10094 | Carbonic anhydrase 6 | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | -1.8 | Downregulated | Homo sapiens | 29534707 | 2018 | P23280 | Protein | MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYNPSLKGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRMTVADGTVYIAQQMHFHWGGASSEISGSEHTVDGIRHVIEIHIVHYNSKYKSYDIAQDAPDGLAVLAAFVEVKNYPENTYYSNFISHLANIKYPGQRTTLTGLDVQDMLPRNLQHYYTYHGSLTTPPCTENVHWFVLADFVKLSRTQVWKLENSLLDHRNKTIHNDYRRTQPLNHRVVESNFPNQEYTLGSEFQFYLHKIEEILDYLRRALN | ||
SAL_10095 | Carbonic anhydrase 6 | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | Homo sapiens | 29534707 | 2018 | P23280 | Protein | MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYNPSLKGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRMTVADGTVYIAQQMHFHWGGASSEISGSEHTVDGIRHVIEIHIVHYNSKYKSYDIAQDAPDGLAVLAAFVEVKNYPENTYYSNFISHLANIKYPGQRTTLTGLDVQDMLPRNLQHYYTYHGSLTTPPCTENVHWFVLADFVKLSRTQVWKLENSLLDHRNKTIHNDYRRTQPLNHRVVESNFPNQEYTLGSEFQFYLHKIEEILDYLRRALN | ||||
SAL_10096 | Chain C, Human Complement Component C3c | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | Homo sapiens | 29534707 | 2018 | P01024 | Protein | MGPTSGPSLLLLLLTHLPLALGSPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPATNHMGNVTFTIPANREFKSEKGRNKFVTVQATFGTQVVEKVVLVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVNHKLLPVGRTVMVNIENPEGIPVKQDSLSSQNQLGVLPLSWDIPELVNMGQWKIRAYYENSPQQVFSTEFEVKEYVLPSFEVIVEPTEKFYYIYNEKGLEVTITARFLYGKKVEGTAFVIFGIQDGEQRISLPESLKRIPIEDGSGEVVLSRKVLLDGVQNPRAEDLVGKSLYVSATVILHSGSDMVQAERSGIPIVTSPYQIHFTKTPKYFKPGMPFDLMVFVTNPDGSPAYRVPVAVQGEDTVQSLTQGDGVAKLSINTHPSQKPLSITVRTKKQELSEAEQATRTMQALPYSTVGNSNNYLHLSVLRTELRPGETLNVNFLLRMDRAHEAKIRYYTYLIMNKGRLLKAGRQVREPGQDLVVLPLSITTDFIPSFRLVAYYTLIGASGQREVVADSVWVDVKDSCVGSLVVKSGQSEDRQPVPGQQMTLKIEGDHGARVVLVAVDKGVFVLNKKNKLTQSKIWDVVEKADIGCTPGSGKDYAGVFSDAGLTFTSSSGQQTAQRAELQCPQPAARRRRSVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLARSNLDEDIIAEENIVSRSEFPESWLWNVEDLKEPPKNGISTKLMNIFLKDSITTWEILAVSMSDKKGICVADPFEVTVMQDFFIDLRLPYSVVRNEQVEIRAVLYNYRQNQELKVRVELLHNPAFCSLATTKRRHQQTVTIPPKSSLSVPYVIVPLKTGLQEVEVKAAVYHHFISDGVRKSLKVVPEGIRMNKTVAVRTLDPERLGREGVQKEDIPPADLSDQVPDTESETRILLQGTPVAQMTEDAVDAERLKHLIVTPSGCGEQNMIGMTPTVIAVHYLDETEQWEKFGLEKRQGALELIKKGYTQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNLIAIDSQVLCGAVKWLILEKQKPDGVFQEDAPVIHQEMIGGLRNNNEKDMALTAFVLISLQEAKDICEEQVNSLPGSITKAGDFLEANYMNLQRSYTVAIAGYALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEATSYALLALLQLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPDHQELNLDVSLQLPSRSSKITHRIHWESASLLRSEETKENEGFTVTAEGKGQGTLSVVTMYHAKAKDQLTCNKFDLKVTIKPAPETEKRPQDAKNTMILEICTRYRGDQDATMSILDISMMTGFAPDTDDLKQLANGVDRYISKYELDKAFSDRNTLIIYLDKVSHSEDDCLAFKVHQYFNVELIQPGAVKVYAYYNLEESCTRFYHPEKEDGKLNKLCRDELCRCAEENCFIQKSDDKVTLEERLDKACEPGVDYVYKTRLVKVQLSNDFDEYIMAIEQTIKSGSDEVQVGQQRTFISPIKCREALKLEEKKHYLMWGLSSDFWGEKPNLSYIIGKDTWVEHWPEEDECQDEENQKQCQDLGAFTESMVVFGCPN | ||||
SAL_10097 | Cystatin S | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | -1.5 | Homo sapiens | 29534707 | 2018 | P01036 | Protein | MARPLCTLLLLMATLAGALASSSKEENRIIPGGIYDADLNDEWVQRALHFAISEYNKATEDEYYRRPLQVLRAREQTFGGVNYFFDVEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSFEIYEVPWEDRMSLVNSRCQEA | |||
SAL_10098 | Cystatin SA | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | -1.5 | Homo sapiens | 29534707 | 2018 | P09228 | Protein | MAWPLCTLLLLLATQAVALAWSPQEEDRIIEGGIYDADLNDERVQRALHFVISEYNKATEDEYYRRLLRVLRAREQIVGGVNYFFDIEVGRTICTKSQPNLDTCAFHEQPELQKKQLCSFQIYEVPWEDRMSLVNSRCQEA | |||
SAL_10099 | Cytokeratin 9 | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | Homo sapiens | 29534707 | 2018 | P35527 | Protein | MSCRQFSSSYLSRSGGGGGGGLGSGGSIRSSYSRFSSSGGGGGGGRFSSSSGYGGGSSRVCGRGGGGSFGYSYGGGSGGGFSASSLGGGFGGGSRGFGGASGGGYSSSGGFGGGFGGGSGGGFGGGYGSGFGGFGGFGGGAGGGDGGILTANEKSTMQELNSRLASYLDKVQALEEANNDLENKIQDWYDKKGPAAIQKNYSPYYNTIDDLKDQIVDLTVGNNKTLLDIDNTRMTLDDFRIKFEMEQNLRQGVDADINGLRQVLDNLTMEKSDLEMQYETLQEELMALKKNHKEEMSQLTGQNSGDVNVEINVAPGKDLTKTLNDMRQEYEQLIAKNRKDIENQYETQITQIEHEVSSSGQEVQSSAKEVTQLRHGVQELEIELQSQLSKKAALEKSLEDTKNRYCGQLQMIQEQISNLEAQITDVRQEIECQNQEYSLLLSIKMRLEKEIETYHNLLEGGQEDFESSGAGKIGLGGRGGSGGSYGRGSRGGSGGSYGGGGSGGGYGGGSGSRGGSGGSYGGGSGSGGGSGGGYGGGSGGGHSGGSGGGHSGGSGGNYGGGSGSGGGSGGGYGGGSGSRGGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGKSSHS | ||||
SAL_10100 | Fibrinogen beta chain | Diagnostic | Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. | Whole unstimulated saliva (WUS) was collected using standard methods. | ELISA | Whole Saliva | Dental Disorder | Oral lichen planus | Homo sapiens | 29534707 | 2018 | P02675 | Protein | MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLRPAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE "markers" ( "SALID" TEXT UNIQUE, "BiomarkerName" TEXT, "BiomarkerType" TEXT, "SamplingMethod" TEXT, "CollectionMethod" TEXT, "AnalysisMethod" TEXT, "CollectionSite" TEXT, "DiseaseCategory" TEXT, "DiseaseName" TEXT, "DiseaseSubtype" TEXT, "FoldChange" TEXT, "Regulation" TEXT, "Exosomal" TEXT, "Organism" TEXT, "PMID" TEXT, "YearOfPublication" TEXT, "ID" TEXT, "Biomarker" TEXT, "Sequence" TEXT, PRIMARY KEY("SALID") );